Fifth Third Wealth Advisors 13F: New $818K Stake in NGVT

Fifth Third Wealth Advisors opened a new position in Ingevity Corporation (NYSE:NGVT), purchasing 11,555 shares valued at about $817,516. The investment was disclosed in a Form 13F filing with the Securities and Exchange Commission on October 22, 2026.

NGVT Ingevity Corporation

$69.64 ▲ +15.89% year to date

1M 3M YTD

Daily close · Oct 23, 2026

What Changed in Fifth Third Wealth Advisors's Ingevity Position

The firm established a brand-new stake in the specialty chemicals maker during the quarter, ending the period with 11,555 shares. Because this is a newly initiated holding, there was no prior share count or percentage comparison to report. The reported value of the position stood at $817,516 based on the filing details.

Other Institutional Activity in Ingevity

Other large investors adjusted their holdings in Ingevity around the same time. American Century Companies Inc reduced its holdings by 161,592 shares, ending with 1,270,958 shares worth about $88,509,514. Segall Bryant & Hamill, LLC cut its stake by 54,455 shares to hold 1,054,605 shares valued at approximately $73,442,691. Millennium Management Llc lowered its position by 163,377 shares, finishing with 992,049 shares worth roughly $69,086,291. Brown Advisory Inc. trimmed its holdings by 17,956 shares, leaving it with 974,107 shares valued at about $67,836,810. Meanwhile, Royce & Associates LP grew its holdings by 56,899 shares, ending with 940,417 shares worth roughly $65,490,639.

Ingevity Corporation Stock Down 1.5%

Ingevity shares recently traded around $69.64 as of October 24, 2026. The stock sits roughly 1.2% below its 50-day moving average of $70.49 and about 1.9% below its 200-day moving average of $71.00. Over the past year, the shares have ranged from a low of $45.85 to a high of $79.29.

Recent Earnings

Ingevity reported trailing twelve month revenue of $1.16 billion and earnings of $0.69 per share. The company posted a net profit margin of 4.7% and a return on equity of 30.1%. Its next quarterly earnings release is scheduled for November 4, 2026.

Insider Buying and Selling at Ingevity Corporation

Company insiders completed several stock transactions prior to the filing. Officer Terrance M. Dyer disposed of 496 shares on May 28, 2026, with a total value of $33,971. General Counsel Ryan C. Fisher sold 2,709 shares on August 3, 2026, valued at $199,698. Chief Executive Officer David H. Li sold 10,000 shares on August 13, 2026, for $761,750, and followed up by selling another 10,092 shares on August 18, 2026, for $764,673.

About Ingevity

Ingevity Corporation makes activated carbon products, specialty chemicals, and engineered polymers used across various industrial sectors. The company operates through three core divisions focusing on performance materials, performance chemicals, and advanced polymer technologies. Institutional interest remains active as the business approaches its upcoming financial updates.

Bottom Line

Investors are keeping an eye on Ingevity ahead of its upcoming earnings report on November 4, 2026. Future SEC filings will show whether Fifth Third Wealth Advisors and other institutional managers continue adjusting their stakes in the chemical maker.